Assertio Holdings, Inc. Closes Spectrum Pharmaceuticals Transaction
31 juil. 2023 19h27 HE
|
Assertio Holdings, Inc.
Combination of Assertio’s Omni-Channel Digital Sales Capabilities and ROLVEDON In-Person Commercial Team to Enhance Market Access and Growth Across All Products Transaction Expected to be...
Assertio Holdings, Inc. Announces Favorable Vote on Proposed Acquisition of Spectrum Pharmaceuticals
27 juil. 2023 16h01 HE
|
Assertio Holdings, Inc.
Stockholders From Both Assertio and Spectrum Have Overwhelmingly Voted in Support of the Transaction Transaction Expected to be Significantly Accretive to Assertio in 2024 LAKE FOREST, Ill. and...
Moore Kuehn Encourages SYNH, SPPI, ARNC and EMBK Investors to Contact Law Firm
03 juil. 2023 11h37 HE
|
Moore Kuehn
NEW YORK, July 03, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...
ALERT: The M&A Class Action Firm Continues the Investigation of the Merger – MYBF, RXDX, SPPI, TRTN
26 avr. 2023 17h41 HE
|
Monteverde & Associates PC
NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
Assertio Holdings, Inc. to Acquire Spectrum Pharmaceuticals, Inc. in All Stock and CVR Transaction
25 avr. 2023 06h00 HE
|
Assertio Holdings, Inc.; Spectrum Pharmaceuticals, Inc.
Complementary Commercial Growth Platforms Anticipated to Accelerate ROLVEDON™ (eflapegrastim-xnst) Injection Profitability and Diversify Revenue Streams Combination of Assertio’s Omni-Channel...
ROSEN, A TOP RANKED LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action– SPPI
10 janv. 2023 19h15 HE
|
The Rosen Law Firm PA
NEW YORK, Jan. 10, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between...
ROSEN, A LEADING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important Deadline in First Filed Securities Class Action Initiated by the Firm– SPPI
02 janv. 2023 19h30 HE
|
The Rosen Law Firm PA
NEW YORK, Jan. 02, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPPI
23 déc. 2022 17h28 HE
|
The Rosen Law Firm PA
NEW YORK, Dec. 23, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between...
Kaplan Fox Reminds Investors with Losses in Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) of Upcoming Lead Plaintiff Deadline
20 déc. 2022 17h51 HE
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) filed a proposed class action suit in the United States District Court for the Southern District of...
DEADLINE ALERT for SPPI and LDI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
01 nov. 2021 12h15 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Nov. 01, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...